NCT02541565
- Conditions
- Composite Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Stage II Diffuse Large B-Cell Lymphoma
Explore clinical trials studying Stage II Diffuse Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Stage II Diffuse Large B-Cell Lymphoma trial results
Active, Not Recruiting
Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
NCT01959698
- Conditions
- CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States